IVF babies boost profit for Monash

By Maggie Lu Yueyang

The company had a total of 14,287 patient treatments, up 14 per cent on FY13 and achieved a pregnancy success rate of 32 per cent. Monash shares climbed 1. 9 per cent to $1. 66 as of 11. 25am, but have dropped about 10 per cent from its issue price of $1. 85 since its debut.

The pro-forma net profit after tax result was $22. 6 million for the year ending June 30, which was 2. 7 per cent higher than its prospectus forecast and a 23 per cent jump on the previous year.

Monash IVF has attributed pregnancy success rates for beating the full-year profit that was forecast in the IPO prospectus and says it is on track to achieve its goals set out for 2015.

Along with Robert Gottliebsen and Stephen Bartholomeusz, Alan also founded Business Spectator, the popular business news and commentary website.

Alan has been a trusted source of investment advice to Australians for many years, and in 2005 he founded Eureka Report - Australia’s #1 online investment report.

Read more here: Business Spectator


You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>